Skip to Main Content

Author Details

Michael E Carney
John A. Burns School of Medicine, University of Hawaii
1995
102
39
PMIDPaper TitleJournal TitlePublished Year
35191427Two Cases of Mesonephric-like Carcinoma Arising From Endometriosis: Case Report and Review of the Literature.Int J Gynecol Pathol2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
37436712A framework for assessing interactions for risk stratification models: the example of ovarian cancer.J Natl Cancer Inst2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
35290101Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.J Clin Oncol2022
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
32300631A fight-and-flight for life: A rare case of advanced cervical cancer in pregnancy.Gynecol Oncol Rep2020
32028322Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.Epidemiology2020
33078978Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).J Clin Oncol2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
31239549A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol2019
31522838Completeness of salpingectomy intended for ovarian cancer risk reduction.Gynecol Oncol2019
30898391Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.Gynecol Oncol2019
29242937Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial.JAMA Oncol2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
29247577Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.Cancer Sci2018
28604450Low-Volume Lymph Node Metastases in Endometrial Carcinoma.Int J Gynecol Cancer2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28805821Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.Nat Med2017
27054934Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.Obstet Gynecol2016
27698005Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.Am J Epidemiol2016
27239393Health Disparities in Native Hawaiians and Other Pacific Islanders Following Hysterectomy for Endometrial Cancer.Hawaii J Med Public Health2016
27378695Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.Hum Mol Genet2016
26747452Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2016
26711112Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.Nat Genet2016
26848776A targeted genetic association study of epithelial ovarian cancer susceptibility.Oncotarget2016
26152742Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Clin Cancer Res2015
24190013Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Hum Genet2014
25127988Abnormal CA-125 levels in menopausal women without ovarian cancer.Gynecol Oncol2014
24765559Paraneoplastic syndrome in Hawai'i: a case of dermatomyositis associated with endometrial cancer.Hawaii J Med Public Health2014
23339562Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.BMC Cancer2013
23845225Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.Lancet Oncol2013
23761272Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.Cancer Prev Res (Phila)2013
23462924Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.Cancer Epidemiol Biomarkers Prev2013
23404857Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.Endocr Relat Cancer2013
23456270Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.Cancer Causes Control2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23535730GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet2013
22361336Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.Lancet Oncol2012
22794196Genome-wide association study for ovarian cancer susceptibility using pooled DNA.Twin Res Hum Genet2012
22665579Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.Cancer Epidemiol Biomarkers Prev2012
20635389Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.Int J Cancer2011
21976293Cataract and ovarian carcinoma: is the vitamin D hypothesis alive?Cancer Epidemiol Biomarkers Prev2011
21673961Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.PLoS One2011
  • 1 - 50 of 102

Recommended Authors

Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Boston University Chobanian & Avedisian School of Medicine
Career Start Year 2011
Number of shared co-authors 17
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 1
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 1
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 33
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 14
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 22
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 2
University of British Columbia
Career Start Year 2000
Number of shared co-authors 35
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 6
Beckman Research Institute of City of Hope
Career Start Year 1997
Number of shared co-authors 60
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 4
University of Southern California
Career Start Year 1995
Number of shared co-authors 15
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 5
University of Chicago
Career Start Year 1993
Number of shared co-authors 29
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 10
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 8
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 47
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 5
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 57
University of Calgary, Cumming School of Medicine
Career Start Year 1984
Number of shared co-authors 26
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 87

Collaborators

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 65
Duke School of Medicine
Co-authored papers 51
University of Hawaii Cancer Center
Co-authored papers 43
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 42
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 40
Cedars-Sinai Medical Center
Co-authored papers 40
Rollins School of Public Health, Emory University
Co-authored papers 39
Mayo Clinic College of Medicine
Co-authored papers 39
University of Michigan School of Public Health ann arbor
Co-authored papers 38
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 38
University of Southern California
Co-authored papers 37
UCL EGA Institute for Women's Health, University College London
Co-authored papers 37
Huntsman Cancer Institute, University of Utah
Co-authored papers 36
College of Nursing, University of South Florida
Co-authored papers 36
Fred Hutchinson Cancer Research Center
Co-authored papers 33
University of Cambridge
Co-authored papers 30
Memorial Sloan-Kettering Cancer Center
Co-authored papers 30
German Cancer Research Center (DKFZ)
Co-authored papers 30
Co-authored papers 29
QIMR Berghofer Medical Research Institute
Co-authored papers 29
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 26
University of California irvine
Co-authored papers 25
Co-authored papers 21
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 21
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 20
National Cancer Institute
Co-authored papers 20
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 20
QIMR Berghofer Medical Research Institute
Co-authored papers 19
Pomeranian Medical University
Co-authored papers 19
National Cancer Institute
Co-authored papers 19